WEBINARS Complimentary:


Kinetics in drug discovery: from assay plate to patient


The screening assays employed in drug discovery are abstractions of biological systems, and by their nature are often poorly predictive of efficacy and potency in patients. This is caused, in part, by the use of equilibrium systems to predict patient responses; despite humans being notoriously non- equilibrium in nature. This talk will describe the use and analysis of kinetic methods across the drug discovery journey and their impact for understanding the pharmacology of medicines.


BMG LABTECH will also introduce the key features of the PHERAstar FSX that supports binding kinetic assays and key factors for assay optimisation to ensure screening success.


To register go to: http://bit.ly/2MmMp4b


Speakers Broadcast date:


November 19, 2019 Time:


15:00 GMT; 10:00 EST and 07:00 PST


Duration: 60 minutes


REGISTRATION IS FREE


A Drug Discovery WorldWebinar sponsored by:


Dr Martin Redhead, UCB


Catherine Wark, BMG LABTECH


Martin Redhead completed his PhD in Pharmacy at the University of Nottingham. He went on to join the Sygnature Discovery Bioscience department working on the kinetics and thermodynamics of drug discovery. He joined UCB in 2015 and works as a group leader, specialising in molecular pharmacology and its impact to drug discovery.


Catherine Wark is the Applications Manager for BMG LABTECH UK, her team is responsible for the support of customers in UK and Ireland. She has 16 years’ experience with BMG LABTECH, assisting users with microplate reader and assay optimisation, drawing from her previous experiences in both academia and industry working in the fields of cell and molecular biology.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68